Home/ Supplements/ Vitamin K/ Vitamin K2+D3

Vitamin K2+D3

product on market Tablet or Pill Bronson Basics Safety: 80/100
80/100

This product is generally safe

  • Vitamin D3: 0.125mg is 1.2× the Tolerable Upper Intake Level (0.1mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin D3 and K2 are supported by strong evidence for promoting calcium absorption and bone mineralization. These nutrients work synergistically to regulate calcium distribution in the body. However, the overall evidence coverage for this specific product profile is very limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Vitamin D3: 0.125mg is 1.2× the Tolerable Upper Intake Level (0.1mg)

Label

Product Label

Label for Vitamin K2+D3
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
120
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

125 mcg (625% DV)
Exceeds UL by 1.2× (UL: 0.1 mg) 608 studies (A:16, B:251)
90 mcg (75% DV)
Within RDA (0.8× RDA) 275 studies (A:9, B:175)

Other Ingredients

Microcrystalline Cellulose Stearic Acid Croscarmellose Sodium Magnesium Stearate Silicon Dioxide Hydroxypropyl Methylcellulose Polyethylene Glycol
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: As a dietary supplement for adults, take 1 tablet daily, preferably with a meal or as directed by a healthcare professional.

Warnings & Precautions

Warning: Do not take this product if you are pregnant or nursing. Consult a healthcare professional before taking this product if you have a medical condition or are taking medication, especially anticoagulant drugs.

Do not use if seal under cap is broken or missing.

Keep out of reach of children.

Formulation Notes

2 in 1 support Bone and heart support

Vitamin K2 as MK-7

GMO-Free Gluten-Free Soy-Free

Lab Tested Made from High Quality Ingredients 365 Day 100% Money Back Guaranteed

Additional Information

Store at room temperature.

Nutrition Questions or Comments? Call 1-800-235-3200 Mon.-Fri. 7 AM- 6PM MST Sat. 8 AM - 4:30 PM MST New

GMP Good Manufacturing Practice

Metadata

Product Details

UPC / SKUX0039K0103
DSLD Entry Date2024-08-22
Product TypeVitamin
FormTablet or Pill
DSLD ID317359
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.